Xianguo Chen Selected Research

Xianguo Chen Research Topics

Disease

9	Neoplasms (Cancer) 12/2021 - 01/2014
8	Prostatitis 03/2024 - 01/2021
6	Pelvic Pain 03/2024 - 01/2021
4	Inflammation (Inflammations) 03/2024 - 08/2018
3	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022 - 01/2014
3	Pain (Aches) 01/2022 - 01/2021
3	Carcinogenesis 12/2021 - 04/2015
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Tuberous Sclerosis (Bourneville's Disease) 12/2021 - 05/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2019 - 12/2011
1	Chronic Pain 03/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Postoperative Pain 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 09/2020
1	Necrosis 12/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2018
1	Brain Ischemia (Cerebral Ischemia) 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 12/2018
1	Leiomyoma (Uterine Fibroids) 05/2016

Drug/Important Bio-Agent (IBA)

4	Mechanistic Target of Rapamycin Complex 1IBA 12/2021 - 04/2015
4	TOR Serine-Threonine KinasesIBA 12/2021 - 04/2015
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 05/2016
3	CytokinesIBA 03/2024 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 01/2014
2	ZincIBA 03/2024 - 01/2023
2	trans-sodium crocetinate (crocetin)IBA 12/2021 - 05/2016
1	AntioxidantsIBA 03/2024
1	InflammasomesIBA 03/2024
1	Butyric Acid (Butanoic Acid)IBA 03/2024
1	EnzymesIBA 03/2024
1	ImmunosorbentsIBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	InterleukinsIBA 03/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Carbon DioxideIBA 01/2023
1	Carbonic Anhydrase IVIBA 01/2023
1	Therapeutic UsesIBA 01/2022
1	plerixafor FDA Link 01/2022
1	HymecromoneIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA 01/2022
1	LigandsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021
1	CP-673,451IBA 10/2021
1	MK 2206IBA 10/2021
1	Selenoprotein PIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	Fluconazole (Zonal)FDA LinkGeneric 09/2020
1	ParaffinIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Long Noncoding RNAIBA 03/2019
1	CreatinineIBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	MacrolidesIBA 12/2018
1	Hormones (Hormone)IBA 08/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2016
1	Celecoxib (Celebrex)FDA Link 05/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2015
1	Insulin ReceptorIBA 01/2015
1	GSK 1838705AIBA 01/2015
1	Docetaxel (Taxotere)FDA Link 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2011
3	Drug Therapy (Chemotherapy) 07/2022 - 01/2014
1	Extracorporeal Shockwave Therapy 10/2022
1	Catheters 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Length of Stay 01/2022
1	Intraperitoneal Injections 12/2018
1	Organ Transplantation 12/2018
1	Immunotherapy 12/2011